neurology

News

Closeup of X-ray photography of human brain

Study adds to HRT and Alzheimer's debate

Hormone replacement therapy (HRT) could cut the risk of Alzheimer's in some women at elevated risk of the disease, according to researchers in the UK.

JP Morgan

JPM2023: Breakthroughs await, but so do roadblocks

Editor-in-chief Jonah Comstock lays out a few of the most potent threads he heard in the conference centres, hotel rooms, and rain-soaked Lyfts of San Francisco.

Digital

Key themes from JP Morgan, with Paul Tunnah – the pharmaphor...

This week, pharmaphorum editor-in-chief Jonah Comstock and pharmaphorum founder Paul Tunnah headed to San Francisco for the JP Morgan conference, the annual elbow-rubbing opportunity for biotech bi

News

After FDA nod, Eisai and Biogen file lecanemab in EU

Eisai and Biogen have moved swiftly ahead with regulatory filings for their new Alzheimer's therapy lecanemab in the EU, after getting a green light for the anti-amyloid beta antibody in th

News

Blockbusters in waiting: Clarivate's drugs to watch in 2023

New drugs for immunological and inflammatory diseases feature prominently among new product launches this year that could top $1 billion in annual sales by 2027 or be clinical "game changer

News

Novartis licenses cocaine use disorder therapy to Stalicla

Swiss biotech Stalicla has continued to diversify its pipeline from a focus on autism therapies with a deal to license Novartis' mavoglurant, in clinical trials for cocaine use disorder (CU

Study adds to HRT and Alzheimer's debate

JPM2023: Breakthroughs await, but so do roadblocks

Key themes from JP Morgan, with Paul Tunnah – the pharmaphor...

After FDA nod, Eisai and Biogen file lecanemab in EU

Blockbusters in waiting: Clarivate's drugs to watch in 2023

Novartis licenses cocaine use disorder therapy to Stalicla

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

neurology

Editor's Picks